1. Home
  2. LPCN vs ANY Comparison

LPCN vs ANY Comparison

Compare LPCN & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • ANY
  • Stock Information
  • Founded
  • LPCN 1997
  • ANY N/A
  • Country
  • LPCN United States
  • ANY United States
  • Employees
  • LPCN N/A
  • ANY N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • ANY Finance: Consumer Services
  • Sector
  • LPCN Health Care
  • ANY Finance
  • Exchange
  • LPCN Nasdaq
  • ANY Nasdaq
  • Market Cap
  • LPCN 16.1M
  • ANY 16.4M
  • IPO Year
  • LPCN N/A
  • ANY N/A
  • Fundamental
  • Price
  • LPCN $2.99
  • ANY $0.70
  • Analyst Decision
  • LPCN Strong Buy
  • ANY Strong Buy
  • Analyst Count
  • LPCN 2
  • ANY 1
  • Target Price
  • LPCN $9.00
  • ANY $3.00
  • AVG Volume (30 Days)
  • LPCN 16.6K
  • ANY 552.0K
  • Earning Date
  • LPCN 11-06-2025
  • ANY 11-13-2025
  • Dividend Yield
  • LPCN N/A
  • ANY N/A
  • EPS Growth
  • LPCN N/A
  • ANY N/A
  • EPS
  • LPCN N/A
  • ANY N/A
  • Revenue
  • LPCN $4,208,119.00
  • ANY $10,831,000.00
  • Revenue This Year
  • LPCN N/A
  • ANY N/A
  • Revenue Next Year
  • LPCN N/A
  • ANY $36.07
  • P/E Ratio
  • LPCN N/A
  • ANY N/A
  • Revenue Growth
  • LPCN N/A
  • ANY N/A
  • 52 Week Low
  • LPCN $2.68
  • ANY $0.36
  • 52 Week High
  • LPCN $6.17
  • ANY $1.90
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 50.61
  • ANY 61.14
  • Support Level
  • LPCN $2.85
  • ANY $0.66
  • Resistance Level
  • LPCN $3.08
  • ANY $0.73
  • Average True Range (ATR)
  • LPCN 0.09
  • ANY 0.05
  • MACD
  • LPCN 0.01
  • ANY 0.01
  • Stochastic Oscillator
  • LPCN 59.83
  • ANY 70.84

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: